Quaggin Susan E 4

What Happened Susan E. Quaggin, a director of AbbVie Inc. (ABBV), was granted 1,118 restricted stock units (RSUs) on May 8, 2026. The award is reported at $0.00 per unit (total reported value $0) because no cash was paid; the RSUs convert one-for-one into AbbVie common shares only upon certain events (see footnote).

Key Details

• Transaction date: 2026-05-08; Form 4 filed: 2026-05-12 (filed within the standard 2 business-day window).
• Transaction type/code: Award/Grant (A).
• Grant size: 1,118 RSUs; reported price: $0.00; reported total: $0.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnote: These RSUs are under AbbVie’s Amended and Restated 2013 Incentive Stock Program and will be paid one-for-one in common stock upon the earlier of the director’s separation from service, death, or a change in control.

Context This was an equity award, not an open-market purchase or sale. RSU grants are common for non-employee directors as compensation and are contingent on future events, so they do not represent immediate share ownership or a direct cash investment signal.